To study NDRG1 function in breast cancer cells, lentiviral shRNAs targeting NDRG1 and corresponding GFP targeting controls were used to study the effect of reducing NDRG1 protein levels by silencing its expression (Fig. 3a and Additional file 1: Figure S4A). The gene discussed is NDRG1; the disease is breast carcinoma.